Your session is about to expire
← Back to Search
Photodynamic Therapy for Mesothelioma and Lung Cancer
Study Summary
This trial is testing a new way to measure the amount of light given during a cancer treatment called photodynamic therapy. They want to see if this new measure is more accurate than the current method and if it can help doctors decide if the treatment should be stopped or continued.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have brain metastases.Your blood test shows that your creatinine level is higher than 2 mg/dL.Your SGOT or SGPT levels are more than three times the normal limit.I haven't had chemotherapy or radiotherapy in the last 4 weeks and have recovered from any side effects.I am able to get out of my bed or chair and move around.Your platelet count is less than 100,000.Your alkaline phosphatase levels are more than three times the normal limit.Your white blood cell count is less than 4,000.I do not have any severe illnesses or social situations that would stop me from following the study's requirements.My cancer is confirmed to be in the lining of my chest but hasn't spread far.Your bilirubin level in the blood is higher than 2 mg/dL.
- Group 1: Treatment (porfimer sodium, IO-PDT)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the federal government sanctioned Light Dosimetry for Intranoperative Therapy?
"As this is a Phase 1 trial with limited clinical evidence of safety and efficacy, our team has assigned Light Dosimetry for Intranoperative Therapy a score of 1."
Is this research open to new applicants?
"Evidently, this clinical trial is currently open for enrollment. As per the latest edit from June 15th 2022, the experiment was initially posted on September 17th 2021."
How many participants are currently involved in this scientific experiment?
"Affirmative. The records on clinicaltrials.gov demonstrate that recruitment for this trial is ongoing and was initiated on September 17th 2021, with the most recent update being made June 15th 2022. This study requires 12 participants from a single site to complete enrollment."
Are there any precedents to the use of Light Dosimetry for Intranoperative Therapy?
"Currently, 5 studies concerning Light Dosimetry for Intranoperative Therapy are underway with none of them at the Phase 3 stage. Most trials related to this topic occur in Buffalo, New york however there is an additional 6 locations running these experiments."
Share this study with friends
Copy Link
Messenger